How do we achieve informed choice for women considering breast screening?
- PMID: 21723312
- DOI: 10.1016/j.ypmed.2011.06.013
How do we achieve informed choice for women considering breast screening?
Abstract
Objective: In current medical literature, mammography and other cancer screening programs are subject to controversy because of debate about the magnitude and nature of the benefits and harms. This paper discusses the issues around informed choice for women considering breast screening.
Method: We discuss qualitative and quantitative studies of women's attitudes to breast screening and informed choice.
Results: Women view breast screening as a way of avoiding potential regret, and reassurance from normal results is highly valued. Screening participants acknowledge anxiety about false positives but awareness regarding potential overdetection of indolent breast cancer is minimal, and research is needed to assess how better understanding of screening downsides may affect women's views. In any case, weighing up screening advantages and disadvantages is sensitive to personal preferences.
Conclusions: Communicators have an ethical obligation to make balanced information available to women, which is flexible enough to respond to the level of detail and involvement desired by each individual. Many women want to know more and to participate more actively in screening decisions. Techniques have been developed to present balanced information and support individual decision making in ways that are accessible and empowering for the wider community. Evaluations of breast cancer screening must integrate clinical data with evidence on the perspectives of women themselves.
Copyright © 2011 Elsevier Inc. All rights reserved.
Comment in
-
Cancer screening and informed consent. A new French exception?Prev Med. 2011 Dec;53(6):437; author reply 438. doi: 10.1016/j.ypmed.2011.07.007. Epub 2011 Jul 22. Prev Med. 2011. PMID: 21803070 No abstract available.
Similar articles
-
Cancer screening and informed consent. A new French exception?Prev Med. 2011 Dec;53(6):437; author reply 438. doi: 10.1016/j.ypmed.2011.07.007. Epub 2011 Jul 22. Prev Med. 2011. PMID: 21803070 No abstract available.
-
Pre-operative MRI for women with newly diagnosed breast cancer: perspectives on clinician and patient decision-making when evidence is uncertain.Breast. 2010 Feb;19(1):10-2. doi: 10.1016/j.breast.2009.11.005. Breast. 2010. PMID: 20159458 Review.
-
How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial.BMJ Open. 2017 Oct 6;7(10):e016246. doi: 10.1136/bmjopen-2017-016246. BMJ Open. 2017. PMID: 28988168 Free PMC article. Clinical Trial.
-
Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination.Patient Educ Couns. 2012 Nov;89(2):353-9. doi: 10.1016/j.pec.2012.08.003. Epub 2012 Sep 7. Patient Educ Couns. 2012. PMID: 22963769
-
The experience of making treatment decisions for women with early stage breast cancer: a diagrammatic representation.Eur J Cancer Care (Engl). 2005 Jul;14(3):249-55. doi: 10.1111/j.1365-2354.2005.00565.x. Eur J Cancer Care (Engl). 2005. PMID: 15952969 Review.
Cited by
-
Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts: A Health Technology Assessment.Ont Health Technol Assess Ser. 2023 Dec 19;23(9):1-293. eCollection 2023. Ont Health Technol Assess Ser. 2023. PMID: 39364436 Free PMC article.
-
To Consent or Not to Consent to Screening, That Is the Question.Healthcare (Basel). 2023 Mar 30;11(7):982. doi: 10.3390/healthcare11070982. Healthcare (Basel). 2023. PMID: 37046909 Free PMC article.
-
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.Alzheimers Dement. 2022 Oct;18(10):1969-1979. doi: 10.1002/alz.12620. Epub 2022 Feb 25. Alzheimers Dement. 2022. PMID: 35213786 Free PMC article.
-
Perceptions of Conflicting Breast Cancer Screening Recommendations Among Racially/Ethnically Diverse Women: a Multimethod Study.J Gen Intern Med. 2022 Apr;37(5):1145-1154. doi: 10.1007/s11606-021-07336-w. Epub 2022 Jan 11. J Gen Intern Med. 2022. PMID: 35015260 Free PMC article.
-
Analysing the ethics of breast cancer overdiagnosis: a pathogenic vulnerability.Med Health Care Philos. 2019 Mar;22(1):129-140. doi: 10.1007/s11019-018-9852-z. Med Health Care Philos. 2019. PMID: 30030748
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
